STATStoryboardAmerican Science, Shattered Curated bySTATAn eight-decade partnership between universities and the federal government made U.S. science preeminent. It took Trump less than a year to shred that crucial alliance. A multipart series on how the Trump administration has disrupted labs, upended lives, and delayed discoveries
STATStoryboardEmbedded Bias: The struggle over removing race from clinical algorithmsCurated bySTATFor many patients, it comes as a shock to learn that calculators used to guide their care give different answers depending on their race. This series explores how these race-based clinical algorithms came to pervade medicine, the harm they may cause — and why it’s proving so difficult to remove race from the equation. Follow this storyboard for new stories from this series.
STATStoryboardHow doctors coerce sickle cell patients into unwanted sterilizationsCurated bySTATFor decades, physicians have steered sickle cell patients toward sterilization. STAT reporter, Eric Boodman's series reveals that an injustice often relegated to the distant past persists today, and highlights the voices of the foremost experts — those who've lived it. Read the entire ongoing series below.
STATStoryboardSTAT Breakthrough Summit EastCurated bySTATHere you’ll find coverage of the STAT 2024 Breakthrough Summit East, a March 21 event in New York City.
STATStoryboardThe War On Recovery Curated bySTATSTAT is examining how the U.S. denies lifesaving medications — methadone and buprenorphine — to people with opioid addiction. Barely one-fifth of the roughly 2.5 million Americans with opioid use disorder receive treatment, and tens of thousands of lives have been lost. People who obtain these medications use illicit drugs at far lower rates and are at far lower risk of overdose or death. Yet nearly every layer of American society — including government, the entertainment industry, the health c
STATStoryboard2024 STATUS List - The Leaders Shaping The HeadlinesCurated bySTATThe 2024 STATUS List features 50 influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech. Some are big names you’ve surely heard of; others behind-the-scenes players, trying to shake up the status quo. We didn’t shy away from leaders who are controversial. What these 50 people have in common is their impact over the past year, and why they’re worth our readers’ attention in the year ahead. Discover the full list below.
STATStoryboardInvestigating UnitedHealth GroupCurated bySTATIn an explosive investigative series, STAT revealed that health insurers are using an unregulated computer algorithm to override clinicians' judgment and deny care to seriously ill older and disabled patients, highlighting the dangers of using AI in medicine. The algorithm, a form of artificial intelligence, was part of an explicit strategy at the nation’s largest health insurer, UnitedHealth Group, to pay for less care. The series has had an immediate and far-reaching impact in Congress.
STATStoryboardSTAT at JPM 2024Curated bySTATThe JP Morgan Healthcare Conference, the largest event of its kind, annually connects inventors, entrepreneurs and investors in all areas of biotech — health, science and medicine. Here’s our JPM news roundup.
STATStoryboard2023 STAT SummitCurated bySTATHere you’ll find coverage of STAT Summit 2023 (Boston and virtual, Oct. 18-19). Our latest summit analyzes the entire healthcare system via insights from top executives, scientists, patients and researchers.
STATStoryboard2023 STATUS List: The definitive list of leaders in life sciencesCurated bySTATExplore the STATUS List — 46 individuals shaping the future of their fields. Drawn from sectors including biotech and diagnostics, as well as broader arenas like education and policy, each individual has taken extra steps to help others and build community in these often-divisive times. Learn more about these well-known figures and unheralded heroes who are shaping our life science landscape.
STATStoryboardDeath Sentence: Prisoners are dying from hepatitis CCurated bySTATThere is a simple, outright cure for hepatitis C. But state prisons across the country are failing to save hundreds of people who die each year from the virus and related complications. A STAT investigation has found that more than 1,000 incarcerated people died from hepatitis C-related complications in the six years after a curative drug hit the market. The death rate in 2019 was double that of the broader U.S. population.
